Identification of a predictive phosphoproteomic signature of response to atezolizumab and bevacizumab (AB) in patients with advanced hepatocellular carcinoma (aHCC)

被引：0
|
作者：
Sarker, Debashis
Borek, Weronika E.
Pedicona, Federico
Zen, Yoh
Christopher, Josie A.
Karampera, Christina
Campbell, Amy
Khorsandi, Shirin Elizabeth
Dowe, Thomas
Habarwaa, Marwo
Britton, David James
Heaton, Nigel
Cutillas, Pedro Rodriguez
Williamson, Andrew
Dokal, Arran David
机构：
[1] Kings Coll Hosp London, Inst Liver Studies, London, England
[2] Kinomica Ltd, Macclesfield, Cheshire, England
[3] Kings Coll Hosp London, London, England
[4] Queen Mary Univ London, Barts Canc Inst, London, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2631
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Combination of Radiotherapy and Atezolizumab plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Pilot Study
    Hur, Y. J.
    Kim, J.
    Seong, J.
    Lee, C. K.
    Kim, B. K.
    Kim, D. Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E304 - E305
  • [22] Clinical Outcomes With Lenvatinib in Patients Previously Treated With Atezolizumab/Bevacizumab for Advanced Hepatocellular Carcinoma
    Muto, Hisanori
    Kuzuya, Teiji
    Kawabe, Naoto
    Ohno, Eizaburo
    Funasaka, Kohei
    Nagasaka, Mitsuo
    Nakagawa, Yoshihito
    Miyahara, Ryoji
    Shibata, Tomoyuki
    Hashimoto, Senju
    Katano, Yoshiaki
    Hirooka, Yoshiki
    ANTICANCER RESEARCH, 2023, 43 (10) : 4673 - 4682
  • [23] Atezolizumab plus bevacizumab in patients with child-Pugh B advanced hepatocellular carcinoma
    Cheon, Jaekyung
    Kim, Hyeyeong
    Kim, Han Sang
    Kim, Chang Gon
    Kim, Ilhwan
    Kang, Beodeul
    Kim, Chan
    Jung, Sanghoon
    Ha, Yeonjung
    Chon, Hong Jae
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [24] Analysis of varix bleeding after Atezolizumab plus Bevacizumab for advanced hepatocellular carcinoma patients
    Lee, Ahlim
    Kim, Hee Yeon
    JOURNAL OF HEPATOLOGY, 2024, 80 : S458 - S458
  • [25] Analysis of the tumor microenvironment in ineffective patients of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma
    Kobayashi, Kazufumi
    Ogasawara, Sadahisa
    Ishino, Takamasa
    Unozawa, Hidemi
    Nakagawa, Miyuki
    Fujiwara, Kisako
    Sakuma, Takafumi
    Fujita, Naoto
    Kanzaki, Hiroaki
    Koroki, Keisuke
    Nakamura, Masato
    Kiyono, Soichiro
    Kanogawa, Naoya
    Kondo, Takayuki
    Saito, Tomoko
    Nakagawa, Ryo
    Nakamoto, Shingo
    Muroyama, Ryosuke
    Chiba, Tetsuhiro
    Kato, Naoya
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [26] Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience
    Sinner, Friedrich
    Pinter, Matthias
    Scheiner, Bernhard
    Ettrich, Thomas Jens
    Sturm, Niklas
    Gonzalez-Carmona, Maria A.
    Waidmann, Oliver
    Finkelmeier, Fabian
    Himmelsbach, Vera
    De Toni, Enrico N.
    Ben Khaled, Najib
    Mohr, Raphael
    Fruendt, Thorben Wilhelm
    Kuetting, Fabian
    van Boemmel, Florian
    Lieb, Sabine
    Krug, Sebastian
    Bettinger, Dominik
    Schultheiss, Michael
    Jochheim, Leonie S.
    Best, Jan
    Mueller, Christian
    Keitel, Verena
    Venerito, Marino
    CANCERS, 2022, 14 (23)
  • [27] Clinical outcomes and response (R) with atezolizumab plus bevacizumab (AB) or lenvatinib (L) in hepatocellular carcinoma (HCC)
    Persano, M.
    Rimini, M.
    Cascinu, S.
    Scartozzi, M.
    Gardini, A. Casadei
    ANNALS OF ONCOLOGY, 2022, 33 : S1459 - S1459
  • [28] Histologic predictors of response to atezolizumab and bevacizumab in hepatocellular carcinoma biopsies
    Sayadi, A.
    Bouattour, M.
    Burgio, M. Dioguardi
    Albuquerque, M.
    Paradis, V.
    Beaufrere, A.
    VIRCHOWS ARCHIV, 2024, 485 : S70 - S71
  • [29] Cost-effectiveness of atezolizumab and bevacizumab in advanced hepatocellular carcinoma.
    Patel, Kishan
    Stein, Stacey
    Luther, Janki
    Huntington, Scott F.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [30] Characteristics and Prognosis of Patients with Advanced Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab Combination Therapy Who Achieved Complete Response
    Kuzuya, Teiji
    Kawabe, Naoto
    Muto, Hisanori
    Tachi, Yoshihiko
    Ukai, Takeshi
    Wada, Yuryo
    Komura, Gakushi
    Nakano, Takuji
    Tanaka, Hiroyuki
    Nakaoka, Kazunori
    Ohno, Eizaburo
    Funasaka, Kohei
    Nagasaka, Mitsuo
    Miyahara, Ryoji
    Hirooka, Yoshiki
    CURRENT ONCOLOGY, 2024, 31 (10) : 6218 - 6231
12345